Intrinsiqq
FutureTech II Acquisition Corp. logo

FutureTech II Acquisition Corp. Financials

FTII

Compare

All currency values in $ millions unless otherwise noted

Income Statement
DEC 2024
DEC 2023
DEC 2022
6:1 split
DEC 2021
General & Administrative$1$1$0–
Total Operating Expenses$2$1$1–
Non-Operating
Net Interest Expense-$0-$0-$0–
Other Non-Operating Income (Expense)$1$5$2–
EBT (Earnings Before Tax)-$0$4$1–
Income Tax Expense$0$1$0–
Net Income
Net Income-$1$3$1–
EPS (Basic)-$0.12$0.23$0.05–
EPS (Diluted)-$0.12$0.23$0.05–
Weighted Avg Shares (Basic)–––2.5M
Weighted Avg Shares (Diluted)–––2.5M
Shares Outstanding6.0M12.8M15.0M2.5M

FutureTech II Acquisition (FTII) financials: revenue, profit and margins

FutureTech II Acquisition (FTII) generated about n/a in revenue and -$1 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is FutureTech II Acquisition profitable?+

FutureTech II Acquisition reported about -$1 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 18 Aug 2025, covering the period ending 30 Jun 2025, as reported to the SEC. Data last refreshed 1 Sept 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with FTII

CompareIntrinsic value
TECHBio-Techne Corporation
$72.67-0.04%41
OTLKOutlook Therapeutics Inc.
$0.39-3.32%10
SCLXScilex Holding Company
$0.57-12.95%0
ELUTElutia Inc.
$0.89+8.54%20
CRISCuris Inc.
$0.44-7.21%35
INBXInhibrx Biosciences, Inc.
$68.97-7.21%18
CRBUCaribou Biosciences, Inc.
$0.28-8.59%10
ACOGAlpha Cognition Inc.
$9.00+1.69%10

Spot a number that looks wrong? Check it in FTII's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing FTII

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.